For someone with a history of anorexia, atypical anorexia, or restrictive eating behaviors, a medication that makes it easier to eat very little, and that is culturally celebrated for producing weight loss, can become deeply dangerous
Furthermore, recent studies in both laboratory animals and humans increasingly sug-gest that moderate hyperhomocysteinemia impairs endothelial-dependent vasodilation (Bellamy et al, 1999
Understanding GLP-1 Agonists and Their Side Effects GLP-1 agonists, such as exenatide (Byetta), liraglutide (Victoza), and dulaglutide (Trulicity), work by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, leading to improved blood sugar control and reduced appetite
doi:10.1016/j.cct.2023.107176 204
Additionally, the treatment led to decreased levels of several key SASP factors, including IL-1, IL-6, and TGF-, in testicular tissue